Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis

• Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diagnosis and management
• Joint research to enhance dementia diagnosis using the brain neurodegeneration imaging software 'Neurophet AQUA'

SEOUL, South Korea, Nov. 25, 2025 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on 25th that it will collaborate with the Florey Institute of Neuroscience and Mental Health (The Florey) in Australia on joint research using its brain neurodegeneration imaging analysis software, Neurophet AQUA. This collaborative study, titled "Enhanced Dementia Diagnosis (EDD) in Australian Memory Clinics," aims to evaluate the utility of blood-based and other biomarkers in the diagnosis and management of Alzheimer's disease in a real-world clinical setting, including Neurophet's AQUA software. Through this initiative, both parties will accelerate their research collaboration to advance high-precision dementia diagnosis leveraging Neurophet AQUA.Located in Melbourne, Australia, the Florey is the largest brain research center in the Southern Hemisphere, with over 500 researchers and staff. The Florey primarily focuses on studying neurodegenerative diseases that affect cognitive function, as well as depression, schizophrenia, and bipolar disorder.Professor Peter van Wijngaarden, Executive Director and CEO of the Florey and Honorary Professor of Ophthalmology at the University of Melbourne, has a strong research interest in biomarkers of neurodegenerative diseases. "We are delighted to announce this research collaboration with Neurophet," said Professor van Wijngaarden. "Through this partnership, we aim to accelerate research toward advanced dementia diagnosis."Jake Junkil Been, Co-CEO of Neurophet, stated, "Through this joint research collaboration, we plan to drive the global advancement of dementia diagnosis using Neurophet's AI-based brain imaging analysis solutions. We will continue our efforts to clinically validate the effectiveness of biomarkers for the early detection of Alzheimer's disease."About NeurophetNeurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.Major products include brain MRI analysis software "Neurophet AQUA", PET Image Quantitative Analysis Software "Neurophet SCALE PET", Brain imaging treatment planning software for electric and magnetic brain stimulation "Neurophet tES/TMS LAB", Alzheimer's Disease treatment prescription and monitoring software "Neurophet AQUA AD" for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software "Neurophet AQUA MS".Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain diseases with AI technology. 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis

PUNE, India, April 2, 2026 /PRNewswire/ -- EKA Mobility, a leading electric vehicles and technology company, today announced a strong 5X year-on-year volume growth in FY 2025–26, with 1,143 units sold and 1,344 electric commercial vehicles produced. This milestone comes on the back of the company's comprehensive electric vehicle portfolio across segments. During the year, EKA entered the M&HCV truck segment, in addition to its existing bus and SCV portfolio. The company is a Champion OEM under the Auto PLI Scheme and has achieved certification across multiple platforms.

"FY 2025–26 is a defining year for EKA Mobility. We are not only scaling volumes but also expanding our manufacturing footprint by adding a new plant recently and increasing our planned annual capacity to 10,000 buses, 6,000 trucks and 24,000 SCVs. With the widest range of fully homologated, born-electric platforms from last-mile to long-haul, we are uniquely positioned as a full-stack EV company. Our growth across electric buses, small commercial vehicles, and now trucks validates both market demand and our execution capability.

India's transition to clean commercial mobility is accelerating, and EKA is at the forefront driving this shift at scale, with technology, innovation, and global ambition."

— Dr. Sudhir Mehta, Founder & Chairman, EKA Mobility

Strong Business Momentum Across Segments

• Electric Bus Leadership:
  Secured wins under PM e-Bus Sewa and PM E-DRIVE; deployed vehicles across 15+ states including Maharashtra, Gujarat, Uttar Pradesh, Karnataka, and Delhi
• SCV Breakout Year:
  Strong uptake of 3S & 6S passenger vehicles and 3W cargo platforms, accelerating last-mile mobility adoption
• Electric Trucks:
  New Growth Engine: Entry into heavy-duty trucks contributing to growth and expanding presence in logistics electrification
• Hydrogen Fuel Cell:
  Deployed a 9-metre hydrogen fuel cell bus at Cochin International Airport with KPIT Technologies and BPCL; plans to deploy 15 more buses

Key Highlights:

Global Expansion:

• Commenced electric bus deployments in Africa
• Partnership with Kerchanshe Group for CKD assembly and distribution
• Agreement with NBFI Capital for manufacturing in Australia

Manufacturing Scale-Up:

• Two Pune facilities operational; Pithampur plant to be operational shortly
• Planned annual capacity: 10,000 buses, 6,000 trucks and 24,000 SCVs

Retail Network:

• Expanded dealership network; plans to add 120 dealerships in FY27

Order Book Visibility:

• 6,000+ confirmed e-buses to be delivered over the next two years

About EKA Mobility

EKA Mobility is a Pune-based electric vehicle and technology company focused on transforming India's commercial mobility landscape. With a portfolio spanning electric buses, electric trucks, and small commercial vehicles, EKA combines electric vehicle manufacturing with proprietary AI-powered fleet technology to deliver end-to-end mobility solutions.

EKA Mobility is backed by Mitsui & Co., Ltd. (Japan), VDL Groep (Netherlands), Pinnacle Industries Limited, Enam Holdings and the NIIF India-Japan Fund as equity and strategic partners and has expanded its footprint to markets in East Africa, South Africa, and Australia.

To know more about the company, kindly visit: https://ekamobility.com 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

EKA Mobility Achieves 5x Volume Growth